260 related articles for article (PubMed ID: 19929860)
1. Toward extended phenotype matching: a new operational paradigm for the transfusion service.
Klapper E; Zhang Y; Figueroa P; Ness P; Stubbs J; Abumuhor I; Bailey J; Epperson L; Tauscher C; Enriquez E; Hashmi G; Seul M
Transfusion; 2010 Mar; 50(3):536-46. PubMed ID: 19929860
[TBL] [Abstract][Full Text] [Related]
2. A new paradigm for pretransfusion testing with the same perennial limitations.
Westhoff CM; Anstee DJ
Transfusion; 2010 Mar; 50(3):520-1. PubMed ID: 20609198
[No Abstract] [Full Text] [Related]
3. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.
Wilkinson K; Harris S; Gaur P; Haile A; Armour R; Teramura G; Delaney M
Transfusion; 2012 Feb; 52(2):381-8. PubMed ID: 21827505
[TBL] [Abstract][Full Text] [Related]
4. Compatibility testing between the blood of donors and recipients in Nigerians.
Okafor LA; Enebe SA
Trop Geogr Med; 1987 Apr; 39(2):148-51. PubMed ID: 3114929
[TBL] [Abstract][Full Text] [Related]
5. New techniques for compatibility testing.
Plapp FV
Arch Pathol Lab Med; 1989 Mar; 113(3):262-9. PubMed ID: 2493236
[TBL] [Abstract][Full Text] [Related]
6. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
7. A flexible array format for large-scale, rapid blood group DNA typing.
Hashmi G; Shariff T; Seul M; Vissavajjhala P; Hue-Roye K; Charles-Pierre D; Lomas-Francis C; Chaudhuri A; Reid ME
Transfusion; 2005 May; 45(5):680-8. PubMed ID: 15847654
[TBL] [Abstract][Full Text] [Related]
8. [The gel centrifugation test in serologic compatibility testing].
Hitzler W; Bauernfeind U; Schömig-Brekner J; Mathias D
Beitr Infusionsther; 1990; 26():358-61. PubMed ID: 1703871
[TBL] [Abstract][Full Text] [Related]
9. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three low-ionic-strength solutions for routine pretransfusion testing: antibody screening/identification, cross-matching, immune anti-ABO detection, and direct antiglobulin tests.
Kaspi E; Mallié F; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
Transfusion; 2009 Dec; 49(12):2772-3. PubMed ID: 20163691
[No Abstract] [Full Text] [Related]
11. [The pretransfusion bedside agglutination test is not a "Gold Standard"].
Levy G
Transfus Clin Biol; 2008 Nov; 15(5):318-21. PubMed ID: 18930684
[TBL] [Abstract][Full Text] [Related]
12. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
[TBL] [Abstract][Full Text] [Related]
13. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
[TBL] [Abstract][Full Text] [Related]
14. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
Hori T; Uemoto S; Takada Y; Oike F; Ogura Y; Ogawa K; Miyagawa-Hayashino A; Yurugi K; Nguyen JH; Hori Y; Chen F; Egawa H
Surgery; 2010 Jun; 147(6):840-4. PubMed ID: 20096431
[TBL] [Abstract][Full Text] [Related]
15. [Manual polybrene test versus saline test as a means of detecting alloantibodies against red cells in the pretransfusion examination].
de Chirinos SM; Lichtiger B
Sangre (Barc); 1991 Feb; 36(1):43-6. PubMed ID: 1853273
[TBL] [Abstract][Full Text] [Related]
16. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
Schonewille H; van de Watering LM; Brand A
Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
18. Optimizing transfusion management of multiple myeloma patients receiving daratumumab-based regimens.
Phou S; Costello C; Kopko PM; Allen ES
Transfusion; 2021 Jul; 61(7):2054-2063. PubMed ID: 33960433
[TBL] [Abstract][Full Text] [Related]
19. Race-related red cell alloantibody problems.
Issitt PD
Br J Biomed Sci; 1994 Jun; 51(2):158-67. PubMed ID: 8049613
[TBL] [Abstract][Full Text] [Related]
20. A microplate method for reverse ABO typing of bloodstains.
Mudd JL
J Forensic Sci; 1986 Apr; 31(2):418-25. PubMed ID: 3711823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
